A Novel ARIH1::BRAF Fusion in a Glioma
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Gao Q, Liang W, Foltz S, Mutharasu G, Jayasinghe R, Cao S
. Driver Fusions and Their Implications in the Development and Treatment of Human Cancers. Cell Rep. 2018; 23(1):227-238.e3.
PMC: 5916809.
DOI: 10.1016/j.celrep.2018.03.050.
View
2.
Chang F, Lin F, Cao K, Surrey L, Aplenc R, Bagatell R
. Development and Clinical Validation of a Large Fusion Gene Panel for Pediatric Cancers. J Mol Diagn. 2019; 21(5):873-883.
PMC: 6734859.
DOI: 10.1016/j.jmoldx.2019.05.006.
View
3.
Hu X, Wang Q, Tang M, Barthel F, Amin S, Yoshihara K
. TumorFusions: an integrative resource for cancer-associated transcript fusions. Nucleic Acids Res. 2017; 46(D1):D1144-D1149.
PMC: 5753333.
DOI: 10.1093/nar/gkx1018.
View
4.
Yang H, Hong D, Cho S, Park Y, Ko W, Kim J
. RhoGAP domain-containing fusions and PPAPDC1A fusions are recurrent and prognostic in diffuse gastric cancer. Nat Commun. 2018; 9(1):4439.
PMC: 6202325.
DOI: 10.1038/s41467-018-06747-4.
View
5.
Wang P, Dai X, Jiang W, Li Y, Wei W
. RBR E3 ubiquitin ligases in tumorigenesis. Semin Cancer Biol. 2020; 67(Pt 2):131-144.
DOI: 10.1016/j.semcancer.2020.05.002.
View